What is the price-to-earnings ratio of Sensorion?
The price-earnings ratio of Sensorion is currently 0.
Sensorion P/S 2025
Sensorion P/S
0
Ticker
ALSEN.PA
ISIN
FR0012596468
WKN
A14SVV
As of Oct 4, 2025, Sensorion's P/S ratio stood at 0, a 0% change from the 0 P/S ratio recorded in the previous year.
The Sensorion P/S history
Sensorion Aktienanalyse
What does Sensorion do?
The company Sensorion SA is a French biotechnology company that specializes in developing innovative therapies for hearing and balance disorders. It was founded in 2009 and is headquartered in Montpellier. Sensorion SA's business model is based on researching and developing new drugs that can be used to treat inner ear diseases. These diseases often have severe effects on the quality of life and social interaction of those affected and represent a significant unmet medical need. Sensorion SA aims to develop innovative and effective therapies to address this need. The company specializes in two main areas: hearing disorders and balance disorders. In the field of hearing disorders, Sensorion SA focuses on developing drugs to treat sensorineural hearing loss. These disorders can be caused by various factors such as aging, noise exposure, or genetic predisposition and affect the inner ear. Sensorion SA has a promising pipeline of drugs in clinical development based on different mechanisms of action. These drugs aim to protect the inner ear and restore hearing function. In the field of balance disorders, Sensorion SA focuses on developing new drugs to treat dizziness and vestibular disorders. These disorders can be caused by factors such as aging, medications, or neurological diseases and affect the balance system in the inner ear. Sensorion SA also has a promising pipeline of drugs in clinical development in this area. Sensorion SA's products are not yet available on the market as they are still in development and undergoing clinical trials. However, the company works closely with academic and industry partners to test and validate its drugs. The development of new drugs is a lengthy and costly process that can take many years. However, Sensorion SA is confident that its therapies have the potential to improve the lives of many people. Overall, Sensorion SA has a promising business model based on the development of innovative therapies for hearing and balance disorders. The company has a promising pipeline of drugs in clinical development and works closely with partners to test and validate its products. If successful, their drugs could have a significant impact on the lives of people suffering from these diseases. Sensorion ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Sensorion's P/S Ratio
Sensorion's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Sensorion's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Sensorion's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Sensorion’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Sensorion stock
How has the price-earnings ratio of Sensorion changed compared to last year?
The price-to-earnings ratio of Sensorion has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Sensorion high compared to other companies?
Yes, the price-to-earnings ratio of Sensorion is high compared to other companies.
How does an increase in the price-earnings ratio of Sensorion affect the company?
An increase in the price-earnings ratio of Sensorion would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Sensorion affect the company?
A decrease in the price-earnings ratio of Sensorion would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Sensorion?
Some factors that influence the price-earnings ratio of Sensorion are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Sensorion pay?
Over the past 12 months, Sensorion paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sensorion is expected to pay a dividend of 0 EUR.
What is the dividend yield of Sensorion?
The current dividend yield of Sensorion is .
When does Sensorion pay dividends?
Sensorion pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Sensorion?
Sensorion paid dividends every year for the past 0 years.
What is the dividend of Sensorion?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Sensorion located?
Sensorion is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sensorion kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sensorion from 10/4/2025 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 10/4/2025.
When did Sensorion pay the last dividend?
The last dividend was paid out on 10/4/2025.
What was the dividend of Sensorion in the year 2024?
In the year 2024, Sensorion distributed 0 EUR as dividends.
In which currency does Sensorion pay out the dividend?
The dividends of Sensorion are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Sensorion
Our stock analysis for Sensorion Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sensorion Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
